424 related articles for article (PubMed ID: 31660033)
21. In vitro resistance to interferon of hepatitis B virus with precore mutation.
Wang Y; Wei L; Jiang D; Cong X; Fei R; Xiao J; Wang Y
World J Gastroenterol; 2005 Feb; 11(5):649-55. PubMed ID: 15655815
[TBL] [Abstract][Full Text] [Related]
22. High expression of hepatitis B virus based vector with reporter gene in hepatitis B virus infection system.
Li SH; Huang WG; Huang B; Chen XG
World J Gastroenterol; 2007 May; 13(17):2490-5. PubMed ID: 17552034
[TBL] [Abstract][Full Text] [Related]
23. Efficient genome replication of hepatitis B virus using adenovirus vector: a compact pregenomic RNA-expression unit.
Suzuki M; Kondo S; Yamasaki M; Matsuda N; Nomoto A; Suzuki T; Saito I; Kanegae Y
Sci Rep; 2017 Feb; 7():41851. PubMed ID: 28157182
[TBL] [Abstract][Full Text] [Related]
24. [Construction of recombinant replication competent plasmids containing HBV genome with mutations of precore and basic core promoter].
Wang Y; Jiang D; Wei L; Chen HS; Cong X; Fei R; Wang Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):218-22. PubMed ID: 15640852
[TBL] [Abstract][Full Text] [Related]
25. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.
Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T
Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689
[TBL] [Abstract][Full Text] [Related]
26. [Construction of whole-genome lamivudine-resistant hepatitis B virus mutant and its replication and expression in HepG2 cells].
Sun J; Wang C; Wen SJ; Wang ZH; Hou JL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):991-3. PubMed ID: 17666334
[TBL] [Abstract][Full Text] [Related]
27. [Establishment of a stable cell line replicating hepatitis B virus DNA carrying the reverse transcriptase region derived from a clinical isolate].
Xiang MQ; Cai XF; Zhang WL; Huang AL; Hu JL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):13-8. PubMed ID: 23469784
[TBL] [Abstract][Full Text] [Related]
28. Impact of length of replication competent genome of hepatitis B virus over the differential antigenic secretion.
Amir F; Siddiqui ZI; Farooqui SR; Anwer A; Khan S; Azmi MI; Mehmankhah M; Dohare R; Khan LA; Kazim SN
J Cell Biochem; 2019 Oct; 120(10):17858-17871. PubMed ID: 31310366
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein.
Gordien E; Rosmorduc O; Peltekian C; Garreau F; Bréchot C; Kremsdorf D
J Virol; 2001 Mar; 75(6):2684-91. PubMed ID: 11222692
[TBL] [Abstract][Full Text] [Related]
30. Long-term suppression of hepatitis B virus replication by short hairpin RNA expression using the scaffold/matrix attachment region-based replicating vector system pEPI-1.
Jenke AC; Wilhelm AD; Orth V; Lipps HJ; Protzer U; Wirth S
Antimicrob Agents Chemother; 2008 Jul; 52(7):2355-9. PubMed ID: 18474581
[TBL] [Abstract][Full Text] [Related]
31. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
[TBL] [Abstract][Full Text] [Related]
32. Generation of a human hepatoma cell line supporting efficient replication of a lamivudine resistant hepatitis B virus.
Zhang Y; Zhang Y; Kang Y; Wang J; Liu H; Zhu H; Qin Y; Mao R; Lin X; Lu M; Zhang J
J Virol Methods; 2014 Jun; 201():51-6. PubMed ID: 24583110
[TBL] [Abstract][Full Text] [Related]
33. Naturally occurring 5' preS1 deletions markedly enhance replication and infectivity of HBV genotype B and genotype C.
Li J; Li J; Chen S; Yuan Q; Zhang J; Wu J; Jiang Q; Wang Q; Xia NS; Zhang J; Tong S
Gut; 2021 Mar; 70(3):575-584. PubMed ID: 32571971
[TBL] [Abstract][Full Text] [Related]
34. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
[TBL] [Abstract][Full Text] [Related]
35. The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs.
Weiss L; Kekulè AS; Jakubowski U; Bürgelt E; Hofschneider PH
Virology; 1996 Feb; 216(1):214-8. PubMed ID: 8614990
[TBL] [Abstract][Full Text] [Related]
36. A novel method for nucleos(t)ide analogues susceptibility assay of hepatitis B virus by viral polymerase transcomplementation.
Luo YY; Tao Y; Cai XF; Zhang WL; Long QX; Guo H; Huang AL; Hu JL
Antiviral Res; 2016 Feb; 126():99-107. PubMed ID: 26738784
[TBL] [Abstract][Full Text] [Related]
37. Novel stable HBV producing cell line systems for expression and screening antiviral inhibitor of hepatitis B virus in human hepatoma cell line.
Ogura N; Ogawa K; Watashi K; Ito T; Wakita T
Biochem Biophys Res Commun; 2018 Mar; 498(1):64-71. PubMed ID: 29481805
[TBL] [Abstract][Full Text] [Related]
38. Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.
Walters KA; Tipples GA; Allen MI; Condreay LD; Addison WR; Tyrrell L
Antimicrob Agents Chemother; 2003 Jun; 47(6):1936-42. PubMed ID: 12760870
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
40. Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene.
Torresi J; Earnest-Silveira L; Civitico G; Walters TE; Lewin SR; Fyfe J; Locarnini SA; Manns M; Trautwein C; Bock TC
Virology; 2002 Jul; 299(1):88-99. PubMed ID: 12167344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
